US Patent Issued to Nanoscope Therapeutics on Nov. 4 for "Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof" (Texas Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,977, issued on Nov. 4, was assigned to Nanoscope Therapeutics Inc. (Bedford, Texas).

"Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof" was invented by Samarendra Mohanty (Arlington, Texas) and Subrata Batabyal (Arlington, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention, in one aspect, relates generally to compositions and methods for modulating cellular activities by synthetic opsins. Further, the invention provides method for the use of synthetic opsins for vision restoration and other applications, wherein the amino acid sequence of the synthetic opsin is modified to pr...